Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

University of Southern California

Status: Withdrawn

Conditions: Colorectal Carcinoma; Prostate Carcinoma; Gastric Carcinoma; Malignant Digestive System Neoplasm; Cholangiocarcinoma; Breast Carcinoma; Pancreatic Carcinoma

Treatments: Other: Survey Administration; Other: Interview

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT03563352

0S-17-4 (Other Identifier)

P30CA014089 (U.S. NIH Grant/Contract)

NCI-2018-00948 (Registry Identifier)

Details and patient eligibility

About

This trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate cancer. Learning what participants like and dislike about their current or past used nutritional supplements may help doctor know how to improve them.

Full description

PRIMARY OBJECTIVES:

I. Identify how patients with cancer are obtaining nutrition to support medical management.

SECONDARY OBJECTIVES:

I. Examine associations of gastrointestinal side effects with specific diagnoses and respective medical therapies.

II. Understand how patients access information regarding nutritional supplements.

III. Evaluate patient satisfaction with currently available oral nutritional supplements (ONS).

IV. Identify patient preferences in formulating a novel nutritional supplement.

OUTLINE:

Participants attend an interview over 15 minutes and complete surveys.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ability to comprehend English (both reading and writing)
• Subjects in the inpatient and outpatient setting with the diagnosis of breast cancer, colorectal cancer, upper gastrointestinal cancer (including gastric, pancreatic, and cholangiocarcinoma), or prostate cancer
• Receiving chemotherapy, biologic, or hormonal therapy in the University of Southern California (USC) Norris Comprehensive Cancer Center Day Hospital
• Ability to understand and the willingness to sign a written informed consent

Exclusion criteria

• Patients with a mental disability that makes them unable to understand and respond to the questions
• Patients with reported non-oncologic associated deficits in taste and smell

Trial design

0 participants in 1 patient group

Observational (interview, survey)

Description:

Participants attend an interview over 15 minutes and complete surveys.

Treatment:

Other: Interview

Other: Survey Administration